Full-Time

Pharmaceutical Field Sales Representative

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

No salary listed

Midland, TX, USA + 1 more

More locations: Lubbock, TX, USA

In Person

Must be willing to travel extensively; local and potential overnight travel required.

Category
Sales & Account Management (1)
Required Skills
Sales
Requirements
  • Bachelor's Degree required
  • 2+ years business or customer service experience; sales preferred
  • Pharmaceutical Sales highly preferred
  • Men's Health preferred
  • Proven time-management skills
  • Strong interpersonal and relationship building skills
  • Strong work ethic and drive to succeed in all situations
  • Positive attitude and growth mindset
  • A sense of resourcefulness and ability to overcome challenges/obstacles when working in a new territory
  • Excellent communication skills
  • Ability/willingness to travel extensively and stay at a location for an extended period of time. Local and potential overnight travel is required
  • Valid driver’s license and clean driving record
Responsibilities
  • Meet or exceed all established territory sales plan and objectives, by developing and implementing strategies specific to the assigned territory.
  • Establish and maintain professional relationships with targeted opinion leaders and physicians
  • Effectively plan workdays and sales calls to accomplish activity goals and objectives.
  • Develop and implement special programs within territory to maximize sales opportunities, i.e., speakers' bureau programs, symposia, etc.
  • Complete assigned administrative tasks in a timely, accurate, legible, and organized manner.
  • Communicate a current, effective, and accurate sales presentation to customers.
  • Present a professional sales image in all business matters.
  • Carry out duties and responsibilities in compliance with applicable regulations and Pharma guidelines and operate assigned sales territory within established sales and/or corporate policies, procedures, and standards.
  • Attend regional and national conferences throughout the year.

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Nazaré Access Academy addresses growing US patient access complexity for pharma.
  • PROPENSITY4 transforms disparate data into integrated insights for commercial optimization.
  • Strategic leadership appointments signal potential for streamlined operations and market expansion.

What critics are saying

  • Nazaré brand consolidation cannibalizes legacy divisions' revenue within 6-12 months.
  • IQVIA's integrated platforms directly compete with PROPENSITY4's data analytics services.
  • AI-powered learning platforms displace human-led training, halving demand by 2028.

What makes Inizio Engage unique

  • End-to-end commercialization partner spanning discovery through post-launch lifecycle.
  • Integrated suite connecting medical affairs, data insights, and creative engagement capabilities.
  • 5,000+ professionals across 20+ countries delivering localized pharmaceutical expertise globally.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inizio Engage who can refer or advise you

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMLiVE
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMLiVE
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

Haymarket Media
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.